OmicsVeu Launches An Extensive Line Of Spatial Biology Products For Multiplex Multi-omics
Fremont, Dec. 13, 2022 (GLOBE NEWSWIRE) -- OmicsVeu, a wholly owned subsidiary of BioGenex, is pleased to announce the launch of a broad line of Multiplex Multi-Omics products for spatial biology consisting of a fully automated instrument NanoVIP® with optimized protocols, ready-to-use reagents for SuperPlex Phenotyping, Genotyping & Phenotyping kits, miRNA, mRNA & DNA FISH probes and kits, In Situ Sequencing system:
NanoVIP®: All-in-One fully automated slide staining system from microtome to slides ready for scanning & analysis using cell profiler, the likes. It is designed to automate any manual slide-based (FFPE, FF & CTC samples) assay protocol with intense, reproducible, consistent staining. Read more.
SuperPlex Phenotyping: A multiplexed immunofluorescence (IF) technique that allows the simultaneous detection of multiple protein biomarkers using the same tissue section. Read more.
Genotyping & Phenotyping: Simple & reliable method for the simultaneous co-detection of protein, DNA miRNA & mRNA within the same tissue section. Read more.
miRFISH: A wide range of over 220 plus fluorophore-tagged miRNA probes enable the generation of multiplex miRNA profiling. These super-sensitive probes with high-melting temperatures are designed to detect low-abundant miRNAs. As miRNAs are tissue-specific, they help to diagnose cancer of unknown primary (CUP), poorly differentiated tumors and for the staging of cancer. Read more.
eFISH: This technology enables to detection of RNA & DNA with sub-micron level accuracy by using uniquely labeled fluorophore-tagged barcoded probes. Read more.
In Situ Sequencing: OmicsVeu introduces fully automated spatial transcriptomics sequencing technology with reagents, probes & a ready-to-use complete kit to elucidate transcriptomics profiling. This technology helps to empower CRISPR/CAS-mediated gene editing. Read more.
OmicsVeu is engaged in developing next-generation fully automated systems with optimized kits and ready-to-use reagents to accelerate the pace of Phenotyping, Genotyping, and Transcriptomics. All our products are easy-to-use and deliver reliable, consistent, and reproducible results with fast turnaround. Our systems are also open and work well with user-supplied reagents and have fully open intuitive software and provide ultimate detection sensitivity of a single nucleotide. We provide Premier Customer care and an unconditional performance guarantee.
OmicsVeu was founded to be one of the most innovative companies, accelerating multiplex multi-omics-systems for a better understanding of tumor micro-environment for precise tumor characterization, helping develop new therapeutics and innovative therapies for dramatically improved disease outcomes.
To accelerate the pace of Spatial Biology Research:
Apply for OmicsVeu Spatial Biology Grant Program
CONTACT: 48810 Kato Road, Fremont, CA 94538, USA T: +1 510-824-1400 E: firstname.lastname@example.org W: www.omicsveu.com
Upcoming Life Sciences Events
- April 2023
- Basel: Swiss Biotech Day 2023
- Brussels: Cell and Gene Therapy Summit
- London: BioTrinity 2023
Latest company news
A Total of Approximately 400 Million Yen Investment in Eisai, Ehime University, DNDi and Others for New Drug and Vaccine Development for Neglected Tropical Diseases
United Health Products Provides Update on FDA PMA Application Process
Sai Life Sciences and NIIT Foundation partner to create livelihood opportunities for underserved communities in Hyderabad